NCT05385458

Brief Summary

A randomized 2-group controlled trial will be conducted to explore the potential effect and potential feasibility of a new Acceptance and Commitment Therapy (ACT) tele-counselling program to improve mental health services for family caregivers of persons with dementia in the province of New Brunswick in Canada. The ACT tele-counselling program was launched in January 2021 with the aim of improving access to high quality psychotherapy for family caregivers, particularly in rural areas. A target sample size of 80 participants will be recruited and randomly allocated to either the ACT program or to usual care services. Mixed methods (QUANTITATIVE + qualitative) will be used to evaluate the potential impact of the ACT program compared to usual care on participant's mental health, and to generate recommendations for the expansion and continuation of the program outside of the province.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 21, 2022

Completed
2 months until next milestone

First Posted

Study publicly available on registry

May 23, 2022

Completed
7 days until next milestone

Study Start

First participant enrolled

May 30, 2022

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 25, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 25, 2023

Completed
Last Updated

May 3, 2023

Status Verified

April 1, 2023

Enrollment Period

10 months

First QC Date

March 21, 2022

Last Update Submit

April 28, 2023

Conditions

Outcome Measures

Primary Outcomes (4)

  • Change in Baseline Depression, Anxiety and Stress up to 36 weeks as assessed by the Depression, Anxiety and Stress Scale

    The Depression, Anxiety and Stress Scale (DASS-21) scale has 21 items with a 3 point likert scale. Range is 0-189 with higher scores indicating greater symptoms of depression, anxiety and stress.

    Baseline through study completion up to 36 weeks

  • Change in Baseline Caregiver Burden up to 36 weeks as assessed by the Zarit Burden Index

    The Zarit Burden Index (ZBI-12) is a 12 Item questionnaire with 5 point likert scale. Range is 0-48 with higher scores indicating higher symptoms of caregiver burden.

    Baseline through study completion up to 36 weeks

  • Change in Baseline Caregiver Participation in Meaningful and Fulfilling Activities up to 36 weeks as assessed by the Engagement in Meaningful Activities Scale

    The Engagement in Meaningful Activities Scale (EMAS) assesses the alignment between a person's actions/activities in daily life and their personal values. Increasing engagement in meaningful activities is a goal of ACT. This scale has 12 items with 5 point likert scale. Range is 12-72 with higher scores indicating higher (better) engagement in meaningful activities.

    Baseline through study completion up to 36 weeks

  • Change in Psychological Flexibility and Experiential Avoidance up to 36 weeks as assessed by the Acceptance and Action Questionnaire

    The Acceptance and Action Questionnaire (AAQ-II) was developed to evaluate the effectiveness of ACT behavioural therapy, which aims to increase psychological flexibility and decrease experiential avoidance. Psychological flexibility refers to a person's ability to recognize and adapt to situational demands; shift perspectives, thinking or behaviours that reduce personal or social functioning; maintain balance among important life domains; and be aware, open, and committed to behaviors that align with personal values (Kashdan, 2010). The questionnaire includes 7 Items with a 7 point likert scale. Range is 7-49 with lower scores indicating higher (better) psychological flexibility and lower (better) experiential avoidance.

    Baseline through study completion up to 36 weeks

Secondary Outcomes (3)

  • Acceptability of ACT Intervention Technology Used for Remote Delivery up to 36 weeks as assessed by the System Usability Scale

    Through study completion up to 36 weeks

  • Satisfaction with ACT Intervention Delivery, Content and Processes up to 36 weeks as assessed by the Client Satisfaction Questionnaire

    Through study completion up to 36 weeks

  • Feasibility and Acceptability of Implementing the ACT Intervention as planned through study completion up to 1 year as assessed by recruitment, retention and attrition rates, and participant demographics

    Through study completion up to 1 year

Study Arms (2)

ACT Intervention

EXPERIMENTAL

Participants will attend 6-8 individual psychotherapy sessions via telephone, text or videoconference. Sessions will last approximately 1 hour and occur every 3-4 weeks. Participants will be enrolled in the Intervention Group for 18-36 weeks. All sessions will be audio recorded. Participants will also be able to attend all available usual care services such as: support groups, First Link, education classes at the Alzheimer Society. Any services utilized will be documented by Alzheimer Society staff.

Behavioral: ACT Intervention

Usual Care

ACTIVE COMPARATOR

Participants will be enrolled as an Alzheimer Society client. Participants will receive 1 First Link 'check-in' telephone call from a staff member at the time of enrolment. Participants will receive a 2nd 'check-in' First Link telephone call from a staff member 3-4 months following enrolment. Participants will be enrolled in the Usual Care Group 12-16 weeks. Participants will also be able to attend all available usual care services such as: support groups, etc. Any services utilized will be documented by Alzheimer Society staff.

Other: Usual Care

Interventions

Acceptance and Commitment Therapy

ACT Intervention

Usual Care Services

Usual Care

Eligibility Criteria

Age19 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult over 19 years old residing in New Brunswick, Canada
  • Able to speak and read English or French
  • Unpaid, informal caregiver to a person living with dementia (no diagnosis required)
  • High level on 2 subscales or less on the Depression, Anxiety and Stress Scale
  • Current or previous use of any mental health services

You may not qualify if:

  • Less than 19 years old or not residing in New Brunswick, Canada
  • Unable to speak and read English or French
  • Not an unpaid informal caregiver to a person living with dementia
  • High level on more than 2 subscales on the Depression, Anxiety and Stress Scale
  • Acute mental health disorder such as: schizophrenia or bipolar disorder

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Alzheimer Society of New Brunswick

Fredericton, New Brunswick, E3A 3R4, Canada

Location

Related Publications (1)

  • Durepos P, Ricketts N, Olthuis JV, Gould ON, Boamah SA, McCloskey R, Lanteigne M, Giberson ER, Caverhill K, Pickford K, MacBean C, Kaasalainen S. Acceptance and Commitment Therapy Tele-Counselling Program With Care Partners of Persons Living With Dementia: A Pilot Feasibility RCT. J Appl Gerontol. 2026 Feb;45(2):225-236. doi: 10.1177/07334648251338303. Epub 2025 May 12.

MeSH Terms

Conditions

Caregiver BurdenPsychological Well-BeingDementia

Condition Hierarchy (Ancestors)

Stress, PsychologicalBehavioral SymptomsBehaviorPersonal SatisfactionBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesNeurocognitive DisordersMental Disorders

Study Officials

  • Pamela Durepos, PhD

    University of New Brunswick

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
One investigator who will have no contact with participants will generate a randomization sequence. The research assistant who enrols participants in the studies will be blinded to the randomization sequence. They will contact the investigator to be told what group the participant is allocated. It is not possible to mask participants. Investigators will be blinded to groups when assessing and comparing outcomes.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Two group randomized controlled trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

March 21, 2022

First Posted

May 23, 2022

Study Start

May 30, 2022

Primary Completion

March 25, 2023

Study Completion

March 25, 2023

Last Updated

May 3, 2023

Record last verified: 2023-04

Data Sharing

IPD Sharing
Will not share

No IPD will be shared with researchers outside of the study.

Locations